Immunotherapy of allergic contact dermatitis

Immunotherapy

Volumn 3, Issue 8, 2011, Pages 979-996

  Spiewak, Radoslaw ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

allergic contact dermatitis allergy vaccination; contact allergy; contact eczema; contact hypersensitivity; hapten; hyposensitization; immunotherapy; nickel; Rhus; tolerance induction

Indexed keywords

CHEMOKINE RECEPTOR CCR; CHLORMETHINE; CHLORPROTHIXENE; DIMETHYLNITROSAMINE; HAPTEN; HAPTEN ANTIBODY; INTERLEUKIN 12; MUSTARD GAS; NEOARSPHENAMINE; NICKEL; NICKEL SULFATE; OLIVE OIL; PLACEBO; PLANT EXTRACT; PLANT TOXIN; THIOMERSAL; URUSHIOL;

ARTHRITIS; CONTACT ALLERGY; CONTACT DERMATITIS; HUMAN; HYPERSENSITIVITY; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; NICKEL HYPERSENSITIVITY; POISON IVY; PRIORITY JOURNAL; REVIEW; SKIN ALLERGY; SYPHILIS;

ALLERGENS; ANIMALS; DERMATITIS, ALLERGIC CONTACT; HAPTENS; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY; NICKEL;

EID: 80051864541     PISSN: 1750743X     EISSN: 17507448     Source Type: Journal    
DOI: 10.2217/imt.11.89     Document Type: Review

References (123)

1. Draeger H, Wu X, Roelofs-Haarhuis K, Gleichmann E. Nickel allergy versus nickel tolerance: can oral uptake of nickel protect from sensitization? J. Environ. Monit. 6(12), 146N-150N (2004). (Pubitemid 40013058)
2. Spiewak R. Patch testing for contact allergy and allergic Contact Dermatitis Open Allergy J. 1, 42-51 (2008).
3. Spiewak R. Wyprysk kontaktowy. Post. Dermatol. Alergol. 26(5), 375-377 (2009).
4. Spiewak R, Moed H, von Blomberg BM et al. Allergic Contact Dermatitis to nickel: modified in vitro test protocols for better detection of allergen-specific response. Contact Dermatitis 56(2), 63-69 (2007). (Pubitemid 46143944)
5. Spiewak R, Czarnobilska E, Jenner B, Curzytek K, Pietowska J, Obtulowicz K. Contact allergy to nickel: perspectives for reliable laboratory diagnosis. Allergy 62(Suppl. 83), 435 (2007).
6. Novak N, Bieber T. The skin as a target for allergic diseases. Allergy 55(2), 103-107 (2000). (Pubitemid 30106014)
7. Moed H, Boorsma DM, Tensen CP et al. Increased CCL27-CCR10 expression in allergic contact dermatitis: implications for local skin memory. J. Pathol. 204(1), 39-46 (2004). (Pubitemid 39214480)
8. Basketter DA, Jefferies D, Safford BJ et al. The impact of exposure variables on the induction of skin sensitization. Contact Dermatitis 55(3), 178-185 (2006). (Pubitemid 44199276)
9. Fuhlbrigge RC, Weishaupt C. Adhesion molecules in cutaneous immunity. Semin. Immunopathol. 29(1), 45-57 (2007). (Pubitemid 47596389)
10. Veien NK. Systemically induced eczema in adults. Derm. Venereol. Suppl. (Stockh.) 147, 1-58 (1989). (Pubitemid 20007424)
11. Jonuleit H, Schmitt E, Kakirman H, Stassen M, Knop J, Enk AH. Infectious tolerance: human CD25+ regulatory T cells convey suppressor activity to conventional CD4+ T helper cells. J. Exp. Med. 196(2), 255-260 (2002). (Pubitemid 34787515)
12. Cavani A, Nasorri F, Ottaviani C, Sebastiani S, De Pita O, Girolomoni G. Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals. J. Immunol. 171(11), 5760-5768 (2003). (Pubitemid 37467191)
13. Schmidt-Weber C. New T-helper subsets controlling the immune system and tissue cells. Immunotherapy 2(4), 427-429 (2010).
14. Artik S, Gleichmann E, Ruzicka T. Toleranzinduktion gegen Nickel. Vom Tiermodell zum Menschen. Hautarzt 55(11), 1052-1059 (2004). (Pubitemid 40012680)
15. Novak N, Allam JP, Betten H, Haberstok J, Bieber T. The role of antigen presenting cells at distinct anatomic sites: they accelerate and they slow down allergies. Allergy 59(1), 5-14 (2004). (Pubitemid 38167945)
16. Parish IA, Waithman J, Davey GM et al. Tissue destruction caused by cytotoxic T lymphocytes induces deletional tolerance. Proc. Natl. Acad. Sci. USA 106(10), 3901-3906 (2009).
17. Vocanson M, Hennino A, Rozieres A, Poyet G, Nicolas JF. Effector and regulatory mechanisms in allergic contact dermatitis. Allergy 64(12), 1699-1714 (2009).
18. Hahnemann S. Organon der rationellen Heilkunde. Arnoldsche Buchhandlung, Dresden, 1-222 (1810).
19. Dakin R. Remarks on a cutaneous affection produced by certain poisonous vegetables. Am. J. Med. Sci. 7, 98-99 (1829).
20. Deibert O, Menger EF, Wigglesworth AM. Studies in specific hypersensitiveness: relative susceptibility of the American Indian race and the white race to poison ivy. J. Immunol. 8(4), 287-289 (1923).
21. Noon L. Prophylactic inoculation against hay fever. Lancet 177(4580), 1572-1573 (1911).
22. Freeman J. Further observations on the treatment of hay fever by hypodermic inoculations of pollen vaccine. Lancet 178(4594), 814-817 (1911).
23. Sherman WB. Types of allergic reactions. In:Fundamentals of Modern Allergy . Prigal SJ (Ed.).McGraw-Hill, NY, USA, 12-17 (1960).
24. Sulzberger MB. Hypersensitiveness to neoarsphenamine in guinea pigs. I. Experiments in prevention and in desensitization. Arch. Derm. Syph. 20(5), 669-697 (1929).
25. Chase MW. Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc. Soc. Exp. Biol. Med. 61, 257-259 (1946).
26. Coe JE, Salvin SB. The specificity of allergic reactions. VI. Unresponsiveness to simple chemicals. J. Exp. Med. 117, 401-423 (1963).
27. Goebeler M, Trautmann A, Voss A, Brocker EV, Toksoy A, Gillitzer R. Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity. Am. J. Pathol.158(2), 431-440 (2001). (Pubitemid 32158606)
28. Moed H, Boorsma DM, Stoof TJ et al. Nickel-responding T cells are CD4+ CLA+ CD45RO+ and express chemokine receptors CXCR3, CCR4 and CCR10. Br. J. Dermatol. 151(1), 32-41 (2004). (Pubitemid 39061278)
29. Sulzberger MB, Baer RL. Skin sensitization to vesicant agents of chemical warfare. J. Invest. Dermatol. 8(6), 365-393 (1947).
30. Lowney ED. Immunologic unresponsiveness appearing after topical application of contact sensitizers to the guinea pig. J. Immunol. 95(3), 397-403 (1965).
31. Spiewak R, Pietowska J, Curzytek K. Nickel: a unique allergen - from molecular structure to European legislation. Expert Rev. Clin. Immunol. 3(6), 851-859 (2007). (Pubitemid 350120111)
32. Vreeburg KJ, de Groot K, von Blomberg M, Scheper RJ. Induction of immunological tolerance by oral administration of nickel and chromium. J. Dent. Res. 63(2), 124-128 (1984). (Pubitemid 14150655)
33. Vreeburg KJ, van Hoogstraten I, von Blomberg BM, de Groot K, Scheper RJ. Oral induction of immunological tolerance to chromium in the guinea pig. J. Dent. Res. 69(10), 1634-1639 (1990). (Pubitemid 20364424)
34. van Hoogstraten I, Boden D, Von Blomberg ME, Kraal G, Scheper RJ. Persistent immune tolerance to nickel and chromium by oral administration prior to cutaneous sensitization. J. Invest. Dermatol. 99(5), 608-616 (1992).
35. van Hoogstraten I, von Blomberg BM, Boden D, Kraal G, Scheper RJ. Non-sensitizing epicutaneous skin tests prevent subsequent induction of immune tolerance. J. Invest. Dermatol. 102(1), 80-83 (1994). (Pubitemid 24039567)
36. Ishii N, Moriguchi N, Nakajima H, Tanaka S, Amemiya F. Nickel sulfate-specific suppressor T cells induced by nickel sulfate in drinking water. J. Dermatol. Sci. 6(2), 159-164 (1993). (Pubitemid 23341351)
37. Wu X, Roelofs-Haarhuis K, Zhang J et al. Dose dependence of oral tolerance to nickel. Int. Immunol.19(8), 965-975 (2007). (Pubitemid 47386922)
38. van Hoogstraten I, Boos C, Boden D, von Blomberg ME, Scheper RJ, Kraal G. Oral induction of tolerance to nickel sensitization in mice. J. Invest. Dermatol. 101(1), 26-31 (1993). (Pubitemid 23213007)
39. Claessen AM, von Blomberg BM, de Groot J, Wolvers DA, Kraal G, Scheper RJ. Reversal of mucosal tolerance by subcutaneous administration of interleukin-12 at the site of attempted sensitization. Immunology 88(3), 363-367 (1996). (Pubitemid 26225158)
40. Desvignes C, Bour H, Nicolas JF, Kaiserlian D. Lack of oral tolerance but oral priming for contact sensitivity to dinitrofluorobenzene in major histocompatibility complex class II-deficient mice and in CD4+ T cell-depleted mice. Eur. J. Immunol. 26(8), 1756-1761 (1996). (Pubitemid 26283147)
41. Artik S, Haarhuis K, Wu X, Begerow J, Gleichmann E. Tolerance to nickel: oral nickel administration induces a high frequency of anergic T cells with persistent suppressor activity. J. Immunol. 167(12), 6794-6803 (2001). (Pubitemid 33144170)
42. Desvignes C, Etchart N, Kehren J, Akiba I, Nicolas JF, Kaiserlian D. Oral administration of hapten inhibits in vivo induction of specific cytotoxic CD8+ T cells mediating tissue inflammation: a role for regulatory CD4+ T cells. J. Immunol. 164(5), 2515-2522 (2000). (Pubitemid 30115481)
43. Dubois B, Chapat L, Goubier A, Papiernik M, Nicolas JF, Kaiserlian D. Innate CD4+CD25+ regulatory T cells are required for oral tolerance and inhibition of CD8+ T cells mediating skin inflammation. Blood 102(9), 3295-3301 (2003). (Pubitemid 37314769)
44. Ikeda Y, Yasuno H, Sato A, Kawai K. Oral and epicutaneous desensitization in urushiol contact dermatitis in guinea pigs sensitized by 2 methods of different sensitizing potency. Contact Dermatitis 39(6), 286-292 (1998). (Pubitemid 29004846)
45. Shelmire B. The poison ivy plant and its oleoresin. J. Invest. Dermatol. 4(5), 337-348 (1941).
46. Kligman AM. Hyposensitization against Rhus dermatitis. AMA Arch. Derm. 78(1), 47-72 (1958).
47. Epstein WL, Byers VS, Baer H. Induction of persistent tolerance to urushiol in humans. J. Allergy Clin. Immunol. 68(1), 20-25 (1981). (Pubitemid 11079113)
48. Lowney ED. Immunologic unresponsiveness to a contact sensitizer in man. J. Invest. Dermatol. 51(6), 411-417 (1968).
49. Kligman AM. Poison ivy (Rhus) dermatitis: experimental study. AMA Arch. Derm. 77, 149-180 (1958).
50. Hershko K, Weinberg I, Ingber A. Exploring the mango-poison ivy connection: the riddle of discriminative plant dermatitis. Contact Dermatitis 52(1), 3-5 (2005). (Pubitemid 40293081)
51. Geroso AM, Elpern DJ. Some observations on mango and mokihana dermatitis from Hawaii. Contact Dermatitis 26(5), 346-347 (1992).
52. Larsson-Stymne B, Widstrom L. Ear piercing - a cause of nickel allergy in schoolgirls? Contact Dermatitis 13(5), 289-293 (1985). (Pubitemid 16181522)
53. Nielsen NH, Menne T. Nickel sensitization and ear piercing in an unselected Danish population. Glostrup Allergy Study. Contact Dermatitis 29(1), 16-21 (1993). (Pubitemid 23217174)
54. Jensen CS, Lisby S, Baadsgaard O, Volund A, Menne T. Decrease in nickel sensitization in a Danish schoolgirl population with ears pierced after implementation of a nickel-exposure regulation. Br. J. Dermatol. 146(4), 636-642 (2002). (Pubitemid 34437777)
55. Thyssen JP, Uter W, McFadden J et al. The EU Nickel Directive revisited - future steps towards better protection against nickel allergy. Contact Dermatitis 64(3), 121-125 (2011).
56. Thyssen JP, Menne T, Liden C et al. Excessive nickel release from earrings purchased from independent shops and street markets - a field study from Warsaw and London. J. Eur. Acad. Dermatol. Venereol. DOI: 10.1111/j. 1468-3083.2010.03909.x (2011) (Epub ahead of print).
57. Lu LK, Warshaw EM, Dunnick CA. Prevention of nickel allergy: the case for regulation? Dermatol. Clin. 27(2), 155-161 (2009).
58. Todd DJ, Burrows D. Nickel allergy in relationship to previous oral and cutaneous nickel contact. Ulster Med. J. 58(2), 168-171 (1989).
59. Kerosuo H, Kullaa A, Kerosuo E, Kanerva L, Hensten-Pettersen A. Nickel allergy in adolescents in relation to orthodontic treatment and piercing of ears. Am. J. Orthod. Dentofacial Orthop. 109(2), 148-154 (1996).
60. Mortz CG, Lauritsen JM, Bindslev-Jensen C, Andersen KE. Nickel sensitization in adolescents and association with ear piercing, use of dental braces and hand eczema. The Odense Adolescence Cohort Study on Atopic Diseases and Dermatitis (TOACS).Derm. Venereol. 82(5), 359-364 (2002). (Pubitemid 35221788)
61. Johansson K, Kerosuo H, Lammintausta K. Nickel sensitization in orthodontically treated and non-treated female adolescents. Contact Dermatitis 64(3), 132-137 (2011).
62. Jensen CS, Lisby S, Baadsgaard O, Byrialsen K, Menne T. Release of nickel ions from stainless steel alloys used in dental braces and their patch test reactivity in nickel-sensitive individuals. Contact Dermatitis 48(6), 300-304 (2003). (Pubitemid 37330261)
63. Marks JG, Belsito DV, DeLeo VA et al. North American Contact Dermatitis Group patch-test results, 1996-1998. Arch. Dermatol. 136(2), 272-273 (2000). (Pubitemid 30090778)
64. Czarnobilska E, Obtulowicz K, Dyga W, Spiewak R. The most important contact sensitizers in Polish children and adolescents with atopy and chronic recurrent eczema as detected with the extended European Baseline Series. Pediatr. Allergy Immunol. 22(2), 252-256 (2011).
65. Aberer W. Vaccination despite thimerosal sensitivity. Contact Dermatitis 24(1), 6-10 (1991).
66. Forstrom L, Hannuksela M, Kousa M, Lehmuskallio E. Merthiolate hypersensitivity and vaccination. Contact Dermatitis 6(4), 241-245 (1980). (Pubitemid 10034277)
67. Slaweta G, Kiec-Swierczynska M. Alergia kontaktowa u mlodziezy konczacej szkole podstawowa. Przegl. Dermatol. 86(2), 143-147 (1999).
68. Spiewak R. Atopy and contact hypersensitivity: a reassessment of the relationship using objective measures. Ann. Allergy Asthma Immunol. 95(1), 61-65 (2005). (Pubitemid 41022774)
69. Lisi P, Perno P, Ottaviani M, Morelli P. Minimum eliciting patch test concentration of thimerosal. Contact Dermatitis 24(1), 22-26 (1991).
70. Hansson H, Moller H. Patch test reactions to merthiolate in healthy young subjects. Br. J. Dermatol. 83(3), 349-356 (1970).
71. Strickler A. Treatment of dermatitis venenata. J. Cut. Dis. 36(6), 327-331 (1918).
72. Schamberg JF. Desensitization of persons against ivy poison. J. Am. Med. Assoc. 73(16), 1213 (1919).
73. Bivings FL. Successful desensitization and treatment of poison ivy and poison oak poisoning. Arch. Derm. Syphilol. 9, 602-606 (1924).
74. Krause GL, Weidman FD. Ivy poisoning. Preventive treatment, with especial reference to the element of individual susceptibility. J. Am. Med. Assoc. 84(26), 1996-1999 (1925).
75. Templeton HJ. Untoward reactions following toxin treatment for dermatitis venenata. Arch. Derm. Syphilol. 20(1), 83-89 (1929).
76. Hill LW. Certain aspects of allergy in children. A critical review of the recent literature (concluded).N. Engl J. Med. 265(26), 1298-1304 (1961).
77. Falagiani P, Di Gioacchino M, Ricciardi L et al. Systemic nickel allergy syndrome (SNAS): a review. Rev. Port. Imunoalergologia 16(2), 135-147 (2008).
78. Perino A. Nickel and food. Int. J. Immunopathol. Pharmacol. 18(Suppl. 4), 15-17 (2005). (Pubitemid 41652943)
79. Antico A, Soana R. Chronic allergic-like dermatopathies in nickel-sensitive patients. Results of dietary restrictions and challenge with nickel salts. Allergy Asthma Proc. 20(4), 235-242 (1999).
80. Marks JG Jr., Trautlein JJ, Epstein WL, Laws DM, Sicard GR. Oral hyposensitization to poison ivy and poison oak. Arch. Dermatol. 123(4), 476-478 (1987). (Pubitemid 17050335)
81. Sjovall P, Christensen OB, Moller H. Oral hyposensitization in nickel allergy. J. Am. Acad. Dermatol. 17(5), 774-778 (1987). (Pubitemid 17152075)
82. Panzani RC, Schiavino D, Nucera E et al. Oral hyposensitization to nickel allergy. preliminary clinical results. Int. Arch. Allergy Immunol. 107(1-3), 251-254 (1995).
83. Schiavino D, Nucera E, Alonzi C et al. A clinical trial of oral hyposensitization in systemic allergy to nickel. Int. J. Immunopathol. Pharmacol. 19(3), 593-600 (2006). (Pubitemid 44580532)
84. Bagot M, Terki N, Bacha S, Moyse D, Suck C, Revuz J. Desensibilisation per os dans l'eczema de contact au nickel: etude clinico-biologique en double insu contre placebo. Ann. Dermatol. Venereol. 126(6-7), 502-504 (1999). (Pubitemid 29422082)
85. Gawkrodger DJ, Cook SW, Fell GS, Hunter JA. Nickel dermatitis: the reaction to oral nickel challenge. Br. J. Dermatol. 115(1), 33-38 (1986). (Pubitemid 16090168)
86. Hindsen M, Bruze M, Christensen OB. Flare-up reactions after oral challenge with nickel in relation to challenge dose and intensity and time of previous patch test reactions. J. Am. Acad. Dermatol. 44(4), 616-623 (2001). (Pubitemid 32249518)
87. Niebuhr M, Kapp A, Werfel T. Hämatogenes allergisches Kontaktekzem nach oraler Nickelexposition. Hautarzt 60(2), 128-130 (2009).
88. Santucci B, Cristaudo A, Cannistraci C, Picardo M. Nickel sensitivity: effects of prolonged oral intake of the element. Contact Dermatitis 19(3), 202-205 (1988).
89. Vollmer J, Weltzien HU, Gamerdinger K, Lang S, Choleva Y, Moulon C. Antigen contacts by Ni-reactive TCR: typical ab chain cooperation versus a chain-dominated specificity. Int. Immunol. 12(12), 1723-1731 (2000). (Pubitemid 32040845)
90. Gamerdinger K, Moulon C, Karp DR et al. A new type of metal recognition by human T cells: contact residues for peptide-independent bridging of T cell receptor and major histocompatibility complex by nickel. J. Exp. Med. 197(10), 1345-1353 (2003). (Pubitemid 36617781)
91. Straus HW. Artificial sensitization of infants to poison ivy. J. Allergy 2(3), 137-144 (1931).
92. Rostenberg A Jr, Kanof NM. Studies in eczematous sensitizations. J. Invest. Dermatol. 4(6), 505-516 (1941).
93. Vandenberg JJ, Epstein WL. Experimental nickel contact sensitization in man. J. Invest. Dermatol. 41(6), 413-418 (1963).
94. White JM, Goon AT, Jowsey IR et al. Oral tolerance to contact allergens: a common occurrence? A review. Contact Dermatitis 56(5), 247-254 (2007). (Pubitemid 46624097)
95. Smith-Sivertsen T, Tchachtchine V, Lund E. Environmental nickel pollution: does it protect against nickel allergy? J. Am. Acad. Dermatol. 46(3), 460-462 (2002). (Pubitemid 34225419)
96. Spiewak R. Allergische Kontaktdermatitis im Kindesalter. Eine Übersicht und Meta- Analyse. Allergologie 25(7), 374-381 (2002). (Pubitemid 34831086)
97. Dotterud LK, Smith-Sivertsen T. Allergic contact sensitization in the general adult population: a population-based study from Northern Norway. Contact Dermatitis 56(1), 10-15 (2007). (Pubitemid 44924257)
98. Schäfer T, Böhler E, Ruhdorfer S et al. Epidemiology of contact allergy in adults. Allergy 56(12), 1192-1196 (2001). (Pubitemid 33086981)
99. Goncalo S, Goncalo M, Azenha A et al. Allergic contact dermatitis in children. A multicenter study of the Portuguese Contact Dermatitis Group (GPEDC).Contact Dermatitis 26(2), 112-125 (1992).
100. Kalish RS, Wood JA. Induction of hapten-specific tolerance of human CD8+ urushiol (poison ivy)-reactive T lymphocytes. J. Invest. Dermatol. 108(3), 253-257 (1997). (Pubitemid 27116219)
101. Constantine VS, Fuks ZY, Farber EM. Mechlorethamine desensitization in therapy for mycosis fungoides. Topical desensitization to mechlorethamine (nitrogen mustard) contact hypersensitivity. Arch. Dermatol. 111(4), 484-488 (1975).
102. Pariser DM, Childers RC, Kechijian P, Halprin KM, Taylor JR. Intravenous desensitization to mechlorethamine in patients with psoriasis. Arch. Dermatol. 112(8), 1113-1114 (1976).
103. Fernandez de Corres L, Leanizbarrutia I, Munoz D, Bernaola G, Fernandez E, Audicana MT. Multiple sensitizations to plants in a farmer. Contact Dermatitis 17(5), 315-317 (1987). (Pubitemid 17164937)
104. Srinivas CR, Krupashankar DS, Singh KK, Balachandran C, Shenoi SD. Oral hyposensitization in Parthenium dermatitis. Contact Dermatitis 18(4), 242-243 (1988).
105. Handa S, Sahoo B, Sharma VK. Oral hyposensitization in patients with contact dermatitis from Parthenium hysterophorus. Contact Dermatitis 44(5), 279-282 (2001). (Pubitemid 32337001)
106. Molitch M, Poliakoff S. Prevention of dermatitis venenata due to poison ivy in children. Arch. Derm. Syphilol. 33(4), 725-728 (1936).
107. Simon FA, Lotspeich E. Observations on sensitivity to poison ivy. J. Invest. Dermatol. 2(3), 143-150 (1939).
108. Zisserman L, Birch L. The prophylaxis and treatment of poison ivy dermatitis with an extract of Rhus toxicodendron. J. Allergy 10(6), 596-604 (1939).
109. Greenberg S, Mallozzi ED. Experiments in poison ivy sensitivity. Effects of specific injections on the level of sensitivity to quantitative patch tests and on clinical susceptibility. Arch. Derm. Syphilol. 42(2), 290-301 (1940).
110. Shelmire B. Hyposensitization to poison ivy. Arch. Derm. Syphilol. 44(6), 983-998 (1941).
111. Zisserman L. Oral immunization for poison ivy dermatitis. J. Allergy 12(5), 474-476 (1941).
112. Kligman AM. Cashew nut shell oil for hyposensitization against Rhus dermatitis. AMA Arch. Derm. 78(3), 359-363 (1958).
113. Epstein WL, Baer H, Dawson CR, Khurana RG. Poison oak hyposensitization. Evaluation of purified urushiol. Arch. Dermatol. 109(3), 356-360 (1974).
114. Epstein WL, Byers VS, Frankart W. Induction of antigen specific hyposensitization to poison oak in sensitized adults. Arch. Dermatol. 118(9), 630-633 (1982). (Pubitemid 12061432)
115. Troost RJ, Kozel MM, van Helden-Meeuwsen CG et al. Hyposensitization in nickel allergic contact dermatitis: clinical and immunologic monitoring. J. Am. Acad. Dermatol. 32(4), 576-583 (1995).
116. Morris DL. Intradermal testing and sublingual desensitization for nickel. Cutis 61(3), 129-132 (1998). (Pubitemid 128472174)
117. Tammaro A, De Marco G, Persechino S, Narcisi A, Camplone G. Allergy to nickel: first results on patients administered with an oral hyposensitization therapy. Int. J. Immunopathol. Pharmacol. 22(3), 837-840 (2009).
118. Minelli M, Schiavino D, Musca F et al. Oral hyposensitization to nickel induces clinical improvement and a decrease in Th1 and Th2 cytokines in patients with systemic nickel allergy syndrome. Int. J. Immunopathol. Pharmacol. 23(1), 193-201 (2010).
119. Andersen KE, Nielsen GD, Flyvholm MA, Fregert S, Gruvberge B. Nickel in tap water. Contact Dermatitis 9(2), 140-143 (1983). (Pubitemid 13152432)
120. Gammelgaard B. Nickel in tap water. Contact Dermatitis 12(2), 123 (1985).
121. Prystupa K, Rudzki E. Nickel in tap water in Warsaw. Contact Dermatitis 39(6), 326 (1998). (Pubitemid 29004865)
122. Flyvholm MA, Nielsen GD, Andersen A. Nickel content of food and estimation of dietary intake. Z. Lebensm. Unters. Forsch. 179(6), 427-431 (1984). (Pubitemid 15171108)
123. Turi MC, Di Claudio F, Schiavone C et al. Systemic nickel allergy syndrome: an update. Ital. J. Allergy Clin. Immunol. 18, 98-102 (2008).